Chemoinformaics analysis of 13-Methoxydihydronitidine
Molecular Weight | 379.412 | nRot | 3 |
Heavy Atom Molecular Weight | 358.244 | nRig | 25 |
Exact Molecular Weight | 379.142 | nRing | 5 |
Solubility: LogS | -6.445 | nHRing | 2 |
Solubility: LogP | 4.304 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 3 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 55.8527 |
nHD | 0 | BPOL | 31.4573 |
QED | 0.674 |
Synth | 3.179 |
Natural Product Likeliness | 1.05 |
NR-PPAR-gamma | 0.022 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.984 |
Pgp-sub | 0.988 |
HIA | 0.002 |
CACO-2 | -4.797 |
MDCK | 0.0000681 |
BBB | 0.133 |
PPB | 0.902246 |
VDSS | 0.85 |
FU | 0.018495 |
CYP1A2-inh | 0.939 |
CYP1A2-sub | 0.957 |
CYP2c19-inh | 0.897 |
CYP2c19-sub | 0.853 |
CYP2c9-inh | 0.516 |
CYP2c9-sub | 0.888 |
CYP2d6-inh | 0.875 |
CYP2d6-sub | 0.905 |
CYP3a4-inh | 0.858 |
CYP3a4-sub | 0.74 |
CL | 12.188 |
T12 | 0.134 |
hERG | 0.04 |
Ames | 0.565 |
ROA | 0.063 |
SkinSen | 0.85 |
Carcinogencity | 0.848 |
EI | 0.025 |
Respiratory | 0.869 |
NR-Aromatase | 0.824 |
Antiviral | Yes |
Prediction | 0.792012 |